These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma. Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014 [TBL] [Abstract][Full Text] [Related]
7. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381 [TBL] [Abstract][Full Text] [Related]
8. [Incidental carcinoma in thyroid pathology: our experience and review of the literature]. Pezzolla A; Lattarulo S; Milella M; Barile G; Pascazio B; Ciampolillo A; Fabiano G; Palasciano N Ann Ital Chir; 2010; 81(3):165-9. PubMed ID: 21105480 [TBL] [Abstract][Full Text] [Related]
9. Graves' disease and thyroid cancer. Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468 [TBL] [Abstract][Full Text] [Related]
10. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter]. Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789 [TBL] [Abstract][Full Text] [Related]
11. Malignancy rates in operated patients with hyperthyroidism in an area of endemic goiter. Karagulle E; Yildirim S; Karakayali F; Turk E; Moray G Int Surg; 2009; 94(4):325-9. PubMed ID: 20302029 [TBL] [Abstract][Full Text] [Related]
12. [Hyperthyroidism and carcinoma of the thyroid gland]. Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859 [TBL] [Abstract][Full Text] [Related]
13. Thyrotoxicosis does not protect against incidental papillary thyroid cancer. Preece J; Grodski S; Yeung M; Bailey M; Serpell J Surgery; 2014 Nov; 156(5):1153-6. PubMed ID: 25151553 [TBL] [Abstract][Full Text] [Related]
14. Multicentre study of thyroid nodules in patients with Graves' disease. Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060 [TBL] [Abstract][Full Text] [Related]
15. High Rates of Underlying Thyroid Cancer in Patients Undergoing Thyroidectomy for Hyperthyroidism. Alvarez AL; Mulder M; Handelsman RS; Lew JI; Farra JC J Surg Res; 2020 Jan; 245():523-528. PubMed ID: 31450040 [TBL] [Abstract][Full Text] [Related]
16. Thyroid carcinoma in thyrotoxic patients treated by surgery. Pacini F; Elisei R; Di Coscio GC; Anelli S; Macchia E; Concetti R; Miccoli P; Arganini M; Pinchera A J Endocrinol Invest; 1988 Feb; 11(2):107-12. PubMed ID: 3361079 [TBL] [Abstract][Full Text] [Related]
17. Thyroid diseases after treatment of Hodgkin's disease. Hancock SL; Cox RS; McDougall IR N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693 [TBL] [Abstract][Full Text] [Related]
18. Thyroid carcinoma in Graves' disease. Farbota LM; Calandra DB; Lawrence AM; Paloyan E Surgery; 1985 Dec; 98(6):1148-53. PubMed ID: 2866590 [TBL] [Abstract][Full Text] [Related]
19. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves' disease and euthyroid goiter, Cleveland Clinic experience. Ergin AB; Saralaya S; Olansky L Am J Otolaryngol; 2014; 35(6):784-90. PubMed ID: 25128909 [TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer yield in patients with Graves' disease. Stocker DJ; Burch HB Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]